SR9009, otherwise known as "stenabolic," is not a SARM, it is actuallya Rew-ErbA ligand. Professor Thomas Burris from the ScrippsResearch Institute developed the compound to treat patients sufferingfrom the effects of metabolic diseases, such as muscle-wasting andcardiovascular problems.
SR9009 is an "exercise mimetic activating Rev-erb-a, proteins thatregulate cell oxidative function and mitochondrial energy production.edical science hopes to resolve issues like chronic obesity andcongestive heart failure using these Rev-erb-a agonists.
By altering protein levels, Stenabolic mimics the effects of exerciseenhancing mitochondrial function in muscle tissue. The compounoincreases mitochondria production in cells, phasing out damagedmitochondria in a rejuvenation process that heightens energy levels.
SR9009 is a great choice for a cutting cycle, supporting your fat lossStenabolic also makes for an excellent stacking compound with otherSARMs.
According to reviews on the compound, Stenabolic is a potent drug.and only requires minimal doses for an effective biological responseWhen dosing SR9009, the issue with the compound is its half-life.Stenabolic comes with a 4-hour half-life, meaning it fades from yourbloodstream really fast.
lo make any drug work properly, you need a sustained serum level ofthe compound over time, Therefore, if its leaving your system every4-hours, your body is going to have a tough time maintaining anactive dose.
